Results from a phase 1 trial showed the independently reviewed best overall objective response rate was 71% in emactuzumab-treated patients. The Food and Drug Administration (FDA) has granted Fast ...

Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery. Treatment with emactuzumab has received fast ...

AbbVie has won expanded European approval of its blockbuster autoimmune drug Rinvoq for the treatment of adults with giant cell arteritis. AbbVie on Tuesday said the European Commission's nod ...

Fashion giant H&M plans to create digital clones of ... where the careers of many workers are already precarious. Sara Ziff, a model turned labor activist who founded the New York-based non ...

In some rare instances , so-called “giant viruses” can grow to as much as 1,000 times larger than their relatives. But despite the terrifying name, giant viruses aren’t necessarily any more ...

However, a battery health test on a Tesla Model 3 RWD with an LFP battery questions ... more charge-discharge cycles than other Li-ion cell types. The test was performed by Kyle Conner for the ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from ...

AbbVie has picked up another indication for its JAK inhibitor Rinvoq in the EU, becoming the first approved oral therapy for giant cell arteritis (GCA), an autoimmune disease affecting the arteries.

Microsoft researchers claim they’ve developed the largest-scale 1-bit AI model, also known as a “bitnet,” to date. Called BitNet b1.58 2B4T, it’s openly available under an MIT license and ...

With on-off trade tariffs targeting Canada, Mexico, China and Europe, the Trump administration's effort to boost domestic capability may have the reverse effect. Photo: Jim Watson/AFP/Getty Images ...